Norris Medicines Limited (BOM:524414)

India · Delayed Price · Currency is INR

18.70

-0.97 (-4.93%)

At close: Sep 25, 2026

Market Cap	187.01M +16.7%
Revenue (ttm)	76.00M +16.0%
Net Income	-3.67M
EPS	-0.37
Shares Out	10.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,916
Open	20.06
Previous Close	19.67
Day's Range	18.69 - 20.06
52-Week Range	12.00 - 20.06
Beta	-0.48
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About Norris Medicines

Norris Medicines Limited manufactures and sells pharmaceutical formulations in India. The company offers nonsterile dosage products, such as tablets, capsules, liquid orals, and copical ointments, as well as injections and medicinal formulations. Its products include antibiotics, anti-inflammatory/pain management, dermatology, antiemetic, nutrition, gastro, cough/cold, skin and allergy, antimalarial, diabetic, cardiac, anti-malarial, dental, and other medicine products. The company also provides contract and loan license manufacturing services ... [Read more]

Industry Pharmaceutical Preparations

Founded 1990

Employees 18

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524414

Full Company Profile

Financial Performance

In fiscal year 2026, Norris Medicines's revenue was 81.32 million, an increase of 39.72% compared to the previous year's 58.20 million. Losses were -2.81 million, -77.32% less than in 2025.

Financial Statements